porphyrias, hemoglobinopathies and thalassemias

Upload: gerald-john-paz

Post on 07-Jul-2018

226 views

Category:

Documents


0 download

TRANSCRIPT

  • 8/19/2019 Porphyrias, Hemoglobinopathies and Thalassemias

    1/11

    29/02/20

    PORPHYRIAS,HEMOGLOBINOPATHIES ANDTHALASSEMIAS

    PORPHYRIAS:

    Impaired production of hemePrimary cause of porphyrias specific enzyme

    deficiency

    Acquired or hereditary

    ACQUIRED PROPHYRIAS:

    Lead poisoning / plumbism

    Porphyria cutanea tarda

    LEAD POISONING:

    Lead inhibits pyrimidine 5’-nucleotidase

    Basophilic stippling

    Lab profile: hypochromic RBCs withbasophilic stippling, toxic granulation inneutrophils

    PORPHYRIA CUTANEATARDA:

    Acquired or inherited

    Clinical feature: photosensitivity

    Exacerbating factors: Alcohol, ironoverload, hepatic injury

    HEREDITARY PORPHYRIAS:

    1. Acute intermittent porphyria

    2. Congenital erythropoietic porphyria

    3. Hereditary coproporphyria

    4. Variegate porphyria

    5. Erythropoietic protoporphyria

    6. Porphyria cutanea tarda

    7. X-linked erythropoietic protoporphyria

  • 8/19/2019 Porphyrias, Hemoglobinopathies and Thalassemias

    2/11

    29/02/20

    3 hematologically significant:congenital erythropoietic anderythropoietic protoporphyria, X-linked ErythropoieticProtoporphyria

    CONGENITAL ERYTHROPOIETICPORPHYRIA

    Associated with severe photosensitivity,scarring and excessive hair growth,deformity of the fingers and fingernails,reddish discoloration of the teeth andchronic hemolysis

    Werewolf 

    HEMOGLOBINOPATHIES:

    Hemoglobin variants

    Due to the differences in the arrangement ofamino acid in the peptide chain

    Differentiated from one another through:Solubility

    Mobility in an electrophoretic field (cellulose actetatebuffer)

    Electrophoresis

  • 8/19/2019 Porphyrias, Hemoglobinopathies and Thalassemias

    3/11

    29/02/20

    DISEASE VS. TRAIT

    Disease

    either the homozygousoccurrence of the genefor the abnormality or thepossession of aheterozygous, dominantgene that produces ahemolytic condition.

    Trait

    heterozygous andnormallyasymptomatic state

    must be inheritedfrom both parents

    MAJOR GROUPS OFHEMOGLOBINOPATHIES:

    Alpha-hemoglobinopathies: 2nd mostcommon

    Beta hemoglobinopathies: most common

    Gamma hemoglobinopathies

    Zeta hemoglobinopathies

    BETA HBPATHIES

    2 major types:

    Homozygous

    Both beta genes are mutated

    Abnormal Hb becomes the dominant Hb type

    Hb A is absent

    Ex: sickle cell disease (HbSS) and HbC disease (HbCC)

    Heterozygous

    1 beta gene is mutated, other is normal

    Abnormal < Hb A

    Ex: HbS trait (HbAS) and HbC trait (HbAC)

  • 8/19/2019 Porphyrias, Hemoglobinopathies and Thalassemias

    4/11

    29/02/20

    SOME ABNORMAL HEMOGLOBIN:

    1. S2. C3. E4. M-Saskatoon5. M- Milwaukee 16. M- Milwaukee 2 (Hyde

    Park)

    7. Hiroshima8. Rainier9. Bethesda10.Agenogi11.Beth-Irael12.Yoshizuka

    M-SaskatoonM- Milwaukee 1

    M- Milwaukee 2 (Hyde Park)

    Methemoglobinemia and cyanosis

    Hb M

    Hiroshima

    Rainier

    Bethesda

    Associated with increased oxygen affinity

    Agenogi

    Beth-Israel

    Yoshizuka

    Associated with decreased oxygen affinity

  • 8/19/2019 Porphyrias, Hemoglobinopathies and Thalassemias

    5/11

    29/02/20

    HB S

    Glutamic acid on the 6th position of the Beta- chain is replaced by valine

    Defined by structural formula:

    α2β26GluVal

    Reduced oxygen conditions sickling of RBCs

    Homozygous state causes sickle cell anemia

    Heterozygous state has sickle cell trait

    Patients with sickle cell trait seem resistant to P. falciparum

    DITHIONITE TEST FOR HB S

    Principle:

    RBCs lysed by saponin

    Na Dithionite removes oxygen from the test environment

    Not confirmatory, just screening test

    Hb S polymerizes in the resulting deoxygenated state and formssickle

    Precipitate consists of tactoids(liquid crystals)

    Tactoidsreflect and deflect lightTURBID solution (+ result isturbidity)

  • 8/19/2019 Porphyrias, Hemoglobinopathies and Thalassemias

    6/11

    29/02/20

    SODIUM METABISULFITETEST:

    Na metabisulfite: deoxygenates Hb

    Under deoxy state, Hb S causes the formation of sicklecells

    Procedure:

    1 drop of blood (slide) + Na Metabisulfite (2 drops ifnormal Hb; 1 drop if decreased Hb)

    Cover with glass slip and seal with petroleum jelly

    Examine after 1 hour

    * Sometimes RBCs may take on a “holly-leaf” form found in sickle cell trait and reported as positive

    * No sickling after 1 hour allow the prep tostand at room temp for 24 hrs reexamine

    * Sickle cells / holly leaf = Positive result

    * Normal RBCs / slightly crenated = Negative result

    HB C

    Glutamic acid on the 6th position of BETA chain is replaced by lysine

    Structural formula:

    α2β26GluLys

    2 crystals related to Hb C

    Hb SC crystals: “Washington Monument” in appearance; crystals protruding RBCmembrane

    Hb CC crystals: hexagonal, elongated crystals; crystals are formed within the RBCmembrane

  • 8/19/2019 Porphyrias, Hemoglobinopathies and Thalassemias

    7/11

    29/02/20

    HbS

    α2β26GluVal

    HbC

    α2β26GluLys

    THALASSEMIA:

    Greek – “thalassic” anemia (great sea)

    Quantitative defects of globin synthesis

    Reduction or total absence of synthesis of one or more of the globin

    Microcytic and hypochromic anemia

    Other abnormalities: NRBCs ( metarubricytes), polychromasia, basophilicstippling, Target cells

    Alpha thalassemia: alpha globin chains are affected

    Beta thalassemia: beta globin chains are affected

    COOLEY’S ANEMIA

    Described by Cooley and Lee

    Anemia, splenomegaly, mild hepatomegaly and mongoloid facies

    Untreated beta-thalassemia

    GENETIC DEFECTS OF THALASSEMIA

    Reduced or absent transcription of mRNA

    mRNA processing errors

    Translation errors

    Deletion of one or more globin genes

    PATHOPHYSIOLOGY

    1. Reduced or absent production of globin chain(decreased Hb synthesis)

    2. Unequal production of alpha and beta globinchains (decreased RBC survival)

    Alpha thalassemia:

    -α/αα = single gene deletion—silent carrier state

    --/αα or –α/-α = two gene deletion—alphathalassemia minor

    --/-α = three gene deletion—Hb H disease (β4)

    --/-- = four gene deletion—Hb Bart (hydropsfetalis); increased oxygen affinity; (γ4)

  • 8/19/2019 Porphyrias, Hemoglobinopathies and Thalassemias

    8/11

    29/02/20

    Hb H = 4 beta chains“pitted golf ball” / raspberry shaped when stained

    with Brilliant Cresyl Blue

    Hb H vs. Heinz bodies:Hb H inclusions—in multiples and cover the cell surface

    Heinz bodies—eccentrically located and there are veryfew per cell

    MECHANISM OF ALPHA THALASSEMIA

    Can manifest in utero (component of fetal and adult Hb)

    ↓ alpha chain = ↑ gamma chain (fetus)  do not precipitate but forms tetramers (γ4)or Hb Bart

    After 6 months after birth, gamma will be replaced by beta

    It will also for tetramers (β4) or Hb H

    Patients with alpha thalassemia do not have severe ineffective RBCproduction

    As the RBC matures, Hb H will form inclusion bodiesmild hemolyticanemia

    Tissue hypoxia: Hb Bart and Hb H have high affinity to oxygen

    Hydrops fetalis: tissue hypoxiacausing heart failure andmassive edema to the baby

    Beta thalassemia:

    Generally: increased HbA2 and Increased Hb F

    Some clinical syndromes: Silent carrier state Beta thalassemia minor Beta thalassemia major—transfusion dependent Hb < 7g/dL, usually every 2-5 weeks Iron accumulation = chelation [deferoxamine(standard),

    deferasirox and deferiprone(both are oral)] Beta thalassemia intermedia

  • 8/19/2019 Porphyrias, Hemoglobinopathies and Thalassemias

    9/11

    29/02/20

    MECHANISMS IN BETA THALASSEMIA

    The unpaired excess alpha chains will precipitate = inclusion bodies, oxidative

    stress, apoptosis of RBC Ineffective erythropoiesis—premature death of the RBCs in the mar row

    Severe beta thalassemia: asymptomatic at fetal life up to 6 months (Hb F) andmanifests after 6 – 24 months.

    Erythroid hyperplasia (inc. cell number)

    Bone deformities

    Children: lacy/lucent appearance of the bone, “hair on end” skull appearance,frontal bossing, hepatosplenomegaly, jaundice

    Thalassemia can be treated withHematopietic stem cell transplantation

    Hb F induction agents: hydroxyl urea, 5-azacytidine, thalidomine derivatives (gammachains)

    Lentiviral Beta globin chain transfer (2010)

    DIAGNOSIS

    History and physical exam

    Laboratory methods: CBC with PBS

    Retics

    Supravital staining

    Electrophoresis

    HPLC

    Capillary zone electrophoresis (CZE)

    Molecular/ Genetic Testing

    OTHER PROCEDURES:

    Alkali denaturationMost human hemoglobins are denatured on

    exposure to a strong alkali

    Hb F resists alkaline denaturation

  • 8/19/2019 Porphyrias, Hemoglobinopathies and Thalassemias

    10/11

    29/02/20

    OTHER PROCEDURES:

    Kleihauer-betke acid elution slide testAlso used for estimation of fetal maternal hemorrhage

    Make PBS, fix it with ethanol

    Immerse in citrate acid buffer (pH 3.3)

    Adult RBCs are eluted (will appear as ghost cells)

    Hb F resists elution (it will take up the stain)

    FETAL-MATERNAL HEMORRHAGE:leakage of fetal cells into the maternalcirculation is the mechanism throughwhich Rh sensitization arises

    ELUTION:

    The process of extracting one material fromanother by washing with a solvent to removeadsorbed material from an adsorbent

    OTHER PROCEDURES:

    Osmotic fragility testHypochromic RBCs have decreased osmotic fragility

    0.375% saline for 5 mins.

    Normal cells—lysis

    Hypochromic cells—no lysis

  • 8/19/2019 Porphyrias, Hemoglobinopathies and Thalassemias

    11/11

    29/02/20